数字病理学市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPHE100000855
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 226
Buy Now

[研究报告]数字病理市场预计将从2022年的9.5262亿美元增长到2028年的18.924亿美元;预计 2022 年至 2028 年复合年增长率为 12.1%。

市场洞察和分析师观点:

数字病理学包括收购、管理病理信息的共享和解释,包括数字环境中的幻灯片和数据。生成数字幻灯片图像文件,允许对数字病理幻灯片进行高分辨率查看、解释和图像分析。数字病理学使病理学家能够以透明和一致的方式快速远程参与、评估和协作,从而提高效率和生产力。数字病理学的未来最终可能涵盖增强的转化研究、计算机辅助诊断 (CAD) 和个性化医疗。数字病理学提供了仅使用载玻片难以实现的优势,例如改进的分析和减少的错误。数字病理学的显着优势之一是它可以通过多种方式提高短期和长期的生产力。

增长动力和挑战:

定期诊断是每种癌症治疗的第一步。传统的病理服务只能了解肿瘤细胞的位置,而无法了解肿瘤细胞的位置。这使得分享案件进行第二次审查变得困难。数字病理学的使用可以对肿瘤进行深入诊断。用于癌症诊断的数字病理程序通常涉及扫描传统的载玻片,然后将连续图像数字化地合并成单个完整图像,从而复制载玻片上的信息。这些图片与相关的临床/医院或实验室结合在一起,为病理学家提供每种独特癌症状况的综合图片。 2017 年 4 月,飞利浦获得 FDA 批准,可以在美国销售用于初级诊断的飞利浦 IntelliSite 病理学解决方案。随着癌症病例数量的不断增加,检查的复杂性和数量也日益同步。飞利浦 IntelliSite 病理学解决方案通过图像创建、查看和管理系统等促进自动化数字病理学,其中包括超快速病理切片扫描仪以及扫描仪的其他功能。同样,2021年1月,罗氏推出了CE-IVD自动化数字病理算法,能够进行乳腺癌诊断的uPath HER2 Dual ISH图像分析和uPath HER2(4B5)图像分析,这也有助于医疗保健提供者确定每种情况的最佳治疗策略。病人。人工智能用于图像分析算法,帮助病理学家快速、准确地诊断乳腺癌患者。因此,癌症诊断技术的发展正在推动数字病理学市场的增长。

战略见解

报告细分和范围:

“全球数字病理学市场”根据产品、类型、应用、最终用户和地理位置进行细分。根据产品,数字病理市场分为扫描仪、软件、通信系统和存储。根据类型,数字病理学市场分为人类病理学和兽医病理学。根据应用,数字病理市场分为远程会诊、疾病诊断、药物发现以及培训和培训。教育。根据最终用户,数字病理市场分为制药和医疗保健。生物技术公司、医院和学术机构。基于地理位置的数字病理市场分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国、亚太地区其他地区)、中东和美国非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美和非洲中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)

细分分析:

根据产品,数字病理市场进行细分分为扫描仪、软件、存储、通信。扫描仪细分市场在 2021 年占据最大市场份额,预计该细分市场在预测期内的复合年增长率最高,为 12.3%。扫描仪有助于生成快速、可靠且高分辨率的细胞图像。它可以帮助病理学家、组织学家和其他医疗专业人员扫描载玻片并将图像上传到网络上以进行远程访问并与同行协作。扫描仪提供自动细胞成像,用于固定细胞测定以及荧光、相差和透射光。技术进步增加了集成软件和扫描仪,用于进一步分析、编辑、管理和共享虚拟幻灯片。例如,2021 年 4 月,领先的端到端数字病理解决方案提供商 Optra scan 推出了 OS-ultra 320,这是全球首款经济实惠的高速数字病理扫描仪。

病理成像系统使用新的扫描仪技术和病理检查软件将切片数字化。它取代了标准载玻片和显微镜病理学工作流程。病理学家可以借助精密仪器通过数字化载玻片来检查病理工作流程的高质量数字照片。该系统可以将图像存储在计算机中,从而改善病理学工作流程。因此,病理成像系统市场预计将增长。

数字病理学市场(按产品) 2022年和2028年

根据类型,数字病理学市场分为人类病理学和兽医病理学。预计到 2022 年,人类病理学领域将占据最大的市场份额,达到 65.94%,并预计在预测期内复合年增长率最高为 12.5%。人类病理学领域增长的主要驱动因素是癌症研究活动的增加以及研究机构、大学和病理实验室之间不断加强的合作。人类病理学旨在为实验室和临床医生提供对人类疾病具有临床病理学意义的信息。它代表从形态学和临床实验室研究中提取的信息,可直接应用于理解人类疾病。它涵盖了患者护理的各个方面,从诊断测试和治疗建议到使用尖端基因技术和预防疾病。

根据应用,数字病理市场细分为远程会诊、疾病诊断、药物发现和培训&教育。 2021年,药物发现领域可能会占据最大的市场份额,并且预计该领域在未来几年将以最快的速度增长。数字病理学的优势不仅限于提高速度和准确的结果,而且还允许病理学家跨越地理距离向制药和生物技术公司展示他们的专业知识。生物技术和制药公司总是面临着在临床前研究中审查和分析数千张载玻片的问题,数字病理学可自动执行图像分析,提供对难以管理的大量组织病理学数据的即时和智能访问,以最终加快发现过程。公司的研究人员可以在互联网上查看数字幻灯片,这比当前的单一视场图像查看方法有了巨大的改进。

根据最终用户,数字病理学市场分为制药和医疗保健。生物技术公司、医院和学术机构。制药公司生物技术公司重组疫苗细分市场可能会在 2021 年占据最大的市场份额,但预计重组疫苗细分市场在预测期内的复合年增长率最高,为 12.5%。制药和生物技术公司正在采取措施以数字化方式管理其工作;这些公司不断致力于发现药物或疗法的分子和生物标志物。数字病理学通过实现制药公司和研发实验室的数据共享来帮助改变全球药物研究。这些公司通过在患者病情的帮助下收集和分析数据来评估药物。数字病理解决方案帮助这些公司维护记录并对工作流程进行有效的工作流程管理。例如,安捷伦科技、基因泰克等公司正在与人工智能公司合作升级他们的流程,例如病理实验室的数字化和先进的治疗生产。

区域分析:

根据地理位置,数字病理市场分为五个关键区域:北美、欧洲、亚太地区、南美和中东地区。中美洲、中东和非洲非洲。由于慢性病负担日益加重、慢性病管理技术的不断采用、投资的增加、产品的推出以及市场领导者采取的举措,北美可能会在 2021 年占据全球市场的重要份额。预计美国在预测期内将大幅增长。癌症、阿尔茨海默病等慢性疾病病例的不断增加预计将推动数字病理学市场的发展。例如,美国癌症协会2022年报告估计,2022年美国将诊断出约2,36,740例新发肺癌病例。该消息来源还表示,2022年将报告79,000例新发肾癌病例。此外,国际糖尿病联合会 (IDF) 2021 年 12 月的报告估计,到 2021 年,墨西哥将有 1400 万成年人患有糖尿病。此外,根据加拿大政府 2021 年 8 月发布的新闻稿,糖尿病是影响加拿大人的主要慢性疾病,截至 2021 年 8 月,超过 300 万加拿大人和 6.1% 的加拿大成年人面临患糖尿病的高风险。癌症的高负担预计将增加对数字病理学的需求,从而推动市场增长。

欧洲是全球细胞开发市场的第二领先地区。由于法国对数字病理项目、教育和培训项目的支持增加、癌症患病率上升以及数字病理解决方案的采用等因素,德国在预测期内在欧洲数字病理市场中占据最大份额英国举办的会议和德国会议数量的增加可能会促进欧洲数字病理市场的增长,是推动欧洲数字病理市场增长的因素。

行业发展和未来机遇:

全球数字病理市场主要参与者采取的各种举措如下:

  1. 2022 年 6 月,SpIntellx, Inc. 和Inspirata 合作将 SpIntellx HistoMapr-Breast 平台和 Inspirata 的 Dynamyx 软件集成到无缝解决方案中。 HistoMapr-Breast 是唯一一款利用可解释人工智能 (xAI) 力量的计算病理学软件,帮助医疗保健提供者更准确、更高效地诊断、预测和治疗乳腺癌。
  2. 2022 年 6 月,罗氏获得了 CE 认证-IVD 批准,标志着用于数字病理学的下一代 Ventana DP 600 玻片扫描仪。
  3. 2020 年 5 月,Danahar(徕卡生物系统公司)在美国推出了新一代数字病理扫描仪 Aperio GT 450 DX。亚太地区。注册为 CE IVD 和 TGA 的 Aperio GT 450 DX 具有连续加载、非接触式操作以及 40 倍放大倍率下 32 秒的扫描时间,使医疗机构能够扩大数字病理学规模,从而在不牺牲质量的情况下满足不断增长的需求.
  4. 2020 年 7 月,3DHISTECH PANNORAMIC 扫描仪系列的三款主要成员 PANORAMIC 250 Flash III、PANNORAMIC Scan II 和 PANORRAMIC Midi II 及其控制软件进行了升级,以更好地服务于多样化的客户。癌症和药物研究、分子和发育组织学、神经科学等领域的需求。
  5. 2020 年 8 月,病理工作流程解决方案的全球领导者 Danahar(徕卡生物系统公司)宣布在欧洲推出 Aperio GT 450 DX 数字病理扫描仪。这款下一代成像系统在非常成功的 Leica Biosystems 数字病理学虚拟峰会上亮相,并已安装在英国利兹教学医院 NHS Trust NHS 的卓越中心。
  6. 2020 年 10 月,Indica Labs,宣布正式启动 Indica Labs 的企业级、基于云的部署。美国国家癌症研究所 (NCI) 内的软件,包括 HALO、HALO AI、HALO Link 和 HALO AP。这是 Indica Labs 最大的单一部署,可供 NCI 内的数百名用户访问,管理数百万张数字图像,并促进每天对数千张图像的分析。
  7. 2020 年 5 月,病理工作流程解决方案的全球领导者 Danahar(徕卡生物系统公司)与国际医学影像 IT 和网络安全公司 Sectra 宣布合作,寻求合并 510 (k) 美国食品和药物管理局的清关药物管理局(FDA)很快。目标是提供集成的临床数字病理解决方案,以满足学术医疗中心、临床研究组织和大型医院网络等企业级客户的临床需求。

竞争格局和主要公司:

一些著名的数字病理学公司包括 Koninklijke Philips NV、Nikon Corporation、Perkin Elmer, Inc.、Indica Labs、3DHISTECH Ltd.、Danaher、Hamamatsu Photonics KK、F . HOFFMANN-LA ROCHE LTD.、Visiopharm A/S 和 Glencoe Software, Inc 等。这些公司专注于新产品发布和地域扩张,以满足全球不断增长的消费者需求,并增加其专业产品组合的产品范围。他们在全球范围内拥有广泛的影响力,这使他们能够为大量客户提供服务,从而增加他们的数字病理市场份额。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are digital pathology?

Digital pathology comprises the gaining, organizing, sharing, and interpretation of pathology information. The process involves converting the glass slides into digital pathology slides using digital pathology scanning solutions. A digital slide image file is then generated, which allows the high-resolution viewing, interpretation, and image analysis of digital pathology slides.

What are the driving factors for the global digital pathology market across the world?

The factors that are driving the growth of the digital pathology market are rising adoption of digital pathology to enhance lab efficiency and the growing applications of digital pathology in drug development and companion diagnostics.

What is the estimated digital pathology market size in 2022?

The digital pathology market is estimated to be valued at US$ 952.62 million in 2022.

Which segment by product type led the digital pathology market?

The scanner segment is expected to hold the largest share of the market in the global digital pathology market contributing a market share of 55.27% in 2021.

Which region is projected to be the fastest-growing region in the global digital pathology market?

The Asia Pacific is expected to be the fastest-growing region in the digital pathology market over the forecast period due to growing investments from international players in China and India, increasing disposable income, and growing cancer cases in these regions will show promising growth in the digital pathology market.

What is the market CAGR value of the digital pathology market during the forecast period?

The CAGR value of the digital pathology market during the forecasted period of 2022-2028 is 12.1%

What are the growth estimates for the digital pathology market till 2028?

The digital pathology market is expected to be valued at US$ 1892.40 million in 2028.

Who are the major players in the digital pathology market across the globe?

The digital pathology market majorly consists of the players, such as Koninklijke Philips N.V.; Nikon Corporation; Perkin Elmer, Inc.; Indica Labs; 3DHISTECH Ltd.; Hamamatsu Photonics K.K.; F. Hoffmann-La Roche Ltd; Visiopharm A/S; Glencoe Software, Inc.; Danaher Corporation.

The List of Companies - Digital Pathology Market

  1. Koninklijke Philips N.V.
  2. Nikon Corporation
  3. Perkin Elmer, Inc.
  4. Indica Labs
  5. 3DHISTECH Ltd.
  6. Hamamatsu Photonics K.K.
  7. F. Hoffmann-La Roche Ltd
  8. Visiopharm A/S
  9. Glencoe Software, Inc.
  10. Danaher Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports